PerkinElmer

AlphaLISA Binding Kits

OF

蛋白质相互作用和结合穿插在大量的生物过程中。高效,高灵敏度研究大蛋白质相互作用的检测需求变得日益重要。Alpha技术作为一种高度灵活,均匀,免洗方法,非常适合测量蛋白质之间相互作用和大小接近200纳米的复合物。基于微珠的亲近均相测定,Alpha 技术提供了测定许多生物靶标的可能性,包括酶,受体 - 配体相互作用,低亲和力相互作用,第二信使水平,DNA,RNA,蛋白质,肽,糖和小分子。

检测特点及优势特点:

  • 免洗步骤,无分离步骤
  • 易用性:少量加样步骤,快速分析开发
  • 广泛的亲和力:检测强或弱的相互作用,从pM到mM亲和力
  • 距离:测量非常大的蛋白质或抗体复合物 - 跨越200nm或更多
  • 高亲合力:每个珠子上的多个结合位点能够使用纳摩尔浓度的抗体或蛋白质,以及使用低亲和力结合剂

产品与服务 (20)
Filters:

Filters :

应用
  • Protein-protein interactions (19)
  • Protein Analysis & Detection (8)
检测点(200-50,000)
  • 500 (20)
  • 5000 (20)
  • 100 (4)
检测目标
  • FCGR3A (2)
  • TNFα (2)
  • PDGFR (2)
  • PD-L1 (2)
  • PD-1 (2)
  • PDGF-BB (2)
  • FCGR2A (2)
  • CTLA4 (2)
  • EGFR (1)
  • TNRFR3 (1)
  • CD86 (1)
  • LAG3 (1)
  • EGF (1)
  • PCSK9 (1)
  • LDLR (1)
  • TNRFR1 (1)
  • 4-1BB (1)
  • FCGR1 (1)
  • FCGR2B (1)
  • HLA-DRA (1)
  • 4-1BBL (1)
  • CD80 (1)
检测目标类
  • Protein (12)
  • Fc-receptor (6)
  • Cytokine (2)
实验类型
  • In vitro (4)
格式
  • Microplates (4)
目标种
  • Human (13)
  • Mouse (1)
治疗领域
  • Cancer (9)
  • Biologics/Bioprocess (6)
  • Inflammation (2)
  • Cardiovascular (1)

幸运8平台彩票1-12 的 20 产品与服务

幸运8平台彩票

  • FcγR2A/CD32a (167H) AlphaLISA Binding Kit

    This kit is designed for the detection of binding between FCGR2A (CD32a) (167H) and human IgG Fc fragment using a homogeneous AlphaLISA® assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.
  • AlphaLISA Binding Assay kits

    EGF/EGFR AlphaLISA Binding Kit

    The AlphaLISA® EGF/EGFR binding kit is designed for the detection of binding activity between human EGF and EGFR, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • Assay principle for AlphaLISA mouse PD-1/PD-L1 binding assay

    PD-1/PD-L1 (mouse) AlphaLISA Binding Kit

    AlphaLISA®小鼠PD-1/PD-L1结合技术可以在体外和体内研究中,帮助构建和表征小分子和大分子抗小鼠PD-1/PD-L1试剂。该试验也可以测试其他可能的结合配体,例如PD-L2,或表征配体亚区阻碍结合的能力。并且,AlphaLISA®可以通过均相化试验,测定抗人PD-1/PD-L1试剂的小鼠交叉反应性。(无洗脱步骤)
  • AlphaLISA binding assay

    PDGF-BB/PDGFRα (human) AlphaLISA Binding Kit

    This kit is designed for the detection of binding activity between Human PDGF-BB and PDGFRα, using a homogeneous AlphaLISA assay (no wash step). This assay can facilitate the design and development of antibody therapeutics by using competitive binding to PDGF-BB and PDGFRα.
  • AlphaLISA binding assay principle

    PD-1/PD-L1 (human) AlphaLISA Binding Kit

    The AlphaLISA® human PD-1/PD-L1 binding kit is designed for the detection of binding activity between human PD-1 and PD-L1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • Assay principle for AlphaLISA TNFa/TNFR2 binding kit

    TNFα/TNFR2 (human) AlphaLISA Binding Kit

    The AlphaLISA® human TNFα/TNFR2 binding kit is designed for the detection of binding activity between human TNFα and TNFR2, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • Assay principle for the AlphaLISA PCSK9/LDLR binding kit

    PCSK9/LDLR (human) AlphaLISA Binding Kit

    This kit is designed to assess binding and inhibition of human PCSK9 and LDLR, using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapetics using competition assays.
  • Assay principle for LANCE TR-FRET binding assay

    CTLA4-CD86 AlphaLISA Binding Kit

    The AlphaLISA® CTLA-4/CD86 binding kit is designed for the detection of binding activity between human CTLA-4 and CD86, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
  • AlphaLISA immunoassay kits

    FCGR1/CD64 AlphaLISA Binding Kit

    This kit is designed for the detection of binding between FCGR1 (CD64) and human IgG Fc fragment using a homogeneous AlphaLISA® assay (no wash steps). This assay can facilitate the design and development of antibody therapetics by using competitive binding.
  • AlphaLISA immunoassay kits

    FCGR2B/CD32b AlphaLISA Binding Kit

    This kit is designed for the detection of binding between FCGR2B (CD32b) and human IgG Fc fragment using a homogeneous AlphaLISA® assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.
  • AlphaLISA binding assay

    HLA-DRA/LAG3 (human) AlphaLISA Binding Kit

    This kit is designed for the detection of binding activity between Human HLA-DRA and LAG3, using a homogeneous AlphaLISA assay (no wash step). This assay can facilitate the design and development of antibody therapeutics by using competitive binding to HLA-DRA and LAG3.
  • FcRn (human) AlphaLISA Binding Kit

    The AlphaLISA human FcRn binding kit is designed for the detection of binding between FcRn and human IgG using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics using a competition assay format.
  • Jump to: